Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1758.00 | 1870.75 | 0.9397 | 0.9161 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 2177.00 | 1870.75 | 1.1637 | 1.2203 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2073.00 | 1870.75 | 1.1081 | 1.1466 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2095.00 | 1870.75 | 1.1199 | 1.1623 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1909.00 | 1870.75 | 1.0204 | 1.0281 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 684.27 | 2214.00 | 1870.75 | 1.1835 | 1.2462 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1971.00 | 1870.75 | 1.0536 | 1.0733 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 2278.00 | 1870.75 | 1.2177 | 1.2908 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 684.27 | 574.00 | 1870.75 | 0.3068 | -0.1141 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 2091.00 | 1870.75 | 1.1177 | 1.1595 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 2071.00 | 1870.75 | 1.1070 | 1.1452 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 684.27 | 632.00 | 1870.75 | 0.3378 | -0.0533 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2128.00 | 1870.75 | 1.1375 | 1.1857 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2145.00 | 1870.75 | 1.1466 | 1.1977 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 1475.00 | 1870.75 | 0.7885 | 0.6978 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2145.00 | 1870.75 | 1.1466 | 1.1977 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 684.27 | 1953.00 | 1870.75 | 1.0440 | 1.0602 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 684.27 | 662.00 | 1870.75 | 0.3539 | -0.0225 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1791.00 | 1870.75 | 0.9574 | 0.9408 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4356.00 | 4286.50 | 1.0162 | 1.0205 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4413.00 | 4286.50 | 1.0295 | 1.0372 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1434.95 | 4491.00 | 4286.50 | 1.0477 | 1.0599 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3802.00 | 4286.50 | 0.8870 | 0.8537 |
| BT-20 | Erlotinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3892.00 | 4286.50 | 0.9080 | 0.8814 |
| BT-20 | Lapatinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2171.00 | 4286.50 | 0.5065 | 0.2999 |